Drako To Control Publicly Traded Brivo With 92.1% of Voting Power

** *** ******* ** ***** ** become * ******** ****** ******* ***** (background:***** ***** ****** ** $*** ******* Valuation) * *** ****** ********* ******* details ********* *** ***** **** ** controlled *** ******** ******** ******* ***** and ***** ***.

******, ** ******* ***** ******* *********:

• ****** ********* *** ***** *******
• ******** ** *** ****, ********* ***** companies **** **** ********
• *********** ** *** *****
• ************ ** **********
• ***** ***'* ********** **** *****
• *****'* *********** ***** ** ***** *** products

********* **, **** ***** *-* ************ statement** *** ***** *** **** ******.

Ten ***** *** *****, *** *** ****** ************

***** **** ***** * ****-***** ***** structure ***** *****'* ****** **** ** times *** ****** ** ***** **** other ************ ****, ** *** ****** explains:

***** * ****-***** ***** ********* ********** to *** *** **** ** ********* in ****** ** *****, ********* ** New ***** ***** * ****** *****, which **** ***** *** **** *** share, *** *** ***** ***** * Common *****, ***** ****carry *** ***** *** *****. Upon the Closing, all stockholders of Brivo will hold only shares of New Brivo Class A Common Stock, except for the current holder of Brivo Class B common stock and Brivo Series A-1 preferred stock, which holder will hold shares of New Brivo Class B Common Stock. That holder is an affiliate of Dean Drako, the Chairman of Brivo.

92.1% *****

***** ***** **** *** **** **** half ** *** ***** *****, ** will **** ****** *** *** ****** rights, ** ********* *****:

*********** ***** *** ******* **** ****** will *** ************* **.*% ** *** shares ** *** ***** ****** ***** and ** ******** ** **** ************* 92.1% ** *** ***** ******** ** be **** ** *** ******* ** New ***** ****** *****, ** **** case, ******** ** *********** ** ***** shareholders ** ********** **** *** ******** Combination.

**** ** ***** ***** *** **** of *** ****** *** ** ****** has * ******** ********* ********, ***** can ****** ******* ** *** ******* by ****** ** *** ****** *** super-voting ******.

*******

*** ********** ******** * ******** ******* about **** **** ** *******:

** * ***********, **** * *********** stockholder, **. ***** ** ******** ** vote *** ******, *** ****** **** which ** *** ****** *******, ** his *** *********, ***** *** *** always ** ** *** ********* ** our ************ *********. **** ** **. Drako ** ** ****** *** ********, he **** ******** ** **** *** ability ** ******** *** **** *********** voting ***** *** *********** ******* *** outcome ** *** ******* ********* ** our ************ *** ********.

Drako ** *******

***** ******* ** ****, ********** ** did *** **** *** ******* ** add.

Controversial *** ******** ****** *********

***** **** *****-****** ***** ********* ** atypical ** ******** ********, **** **** companies ** *** ****, **** *** most *************** ****-***** **** ***** **** Zuckerberg *** ******** (******** ***** ******* ********* ** **** Zuckerberg’s *****). ***** ***** *** *** ***** Brivo,** ****** ** **** ** ****.

******* **** ***** ***** ****** ** worse, **** **** ** ** **** long-term, ****** **** ********* **** ***** up ** ******* ***** *** * long ****.

Timeline *** ***** *******

*****, *** *** *** **** *********** with *****, ********** *** ***** *********, labeled "****** *" *** "****** *", though *** ***** **********, ** *** filing.

****** * *** ********* ** "* mature ********* *******" **** * **** not **** ** ** *******:

** ******** **, ****, ********* *** initial ****** ********, **. ***** ******* out ** * ******** ******* ** a ******* ******* **** ** ******* portfolio ********* **** ***** *** *****’* acquisition ********. **** **********, *** ******** contact ********* **. ***** **** *** chief ********* ******* ** ****** *, a ****** ********* ******* **** *** most ** *****’* *********** ********.

** ****** **, ****, ****** * informed ***** **** ****** * ** longer ****** ** ****** * ********* business *********** **** *****.

** ** *** **** *** ****** A **.

****** *, ** *******, ** *********, based ** *** ********** **** ****** B ******** ******* ****, ************* ***** *** *** ****-***** *** ****** ***** *** ******** described *****:

** ***** **, ****, ***** ******** a ***-********** ********* **** ****** * and *** ******** **** ******* ****** to ********* ********* ********* **********. ** March **, ****, ***** ********* * draft ****** ** ****** ** ****** B *** *************. ** *** ********** by ***** **** ***** *** *** of ******* ******* ******* *********** ********* (each, * “****”) **** ****** * was *********** *** * ********* ******** combination. ***** ***** *****, ********* ******** to ****** * ******** *************** ** Crown **** ****** * *** ********** to **** * ****** ** ****** with ******* ****.

Executive ************ *** *****

*** ****** **** ********* *** * executives ************ *** *****

**** ****** ******* **** *** ********, says *** ******, ** **** **** "not *** **** ********** ** *** Brivo *****".

************, *** ****** ********* *** ***** grants ** **********, ****** *****:

****, ***** ** *** ******** ** the ***** ******* ** ** *** Chairman *** *** ** ******** ** the *******.

Eagle *** *** *****

*******, *** ****** *** * *** important ******* ***** *** ************ ******* VSaaS ******** ***** *** *** *****, both ********* ***** ***** ********.

***** ** ******* ***** * *** of ***** ***, **** **** **** 10% ** *****'* ***** ******** ~$** million *******, ** *** ********** ***** indicates:

****** *** **** ****** ***** ********* 30, **** *** ****, *** ******* purchased $*.* ******* *** $*.* *******, respectively, ** ************ ******** *** ******** from ***** *** ***** ** ******** in *** **** ** ******** ** the ************ ********* ************ ********** ** operations.

*****'* $* ******* ** ***** *** sales ** **** *** *** ***** 9 ****** ** ****, ** **** a ************ ********** *** **** **** would *** *****'* **** **** ***** Eye ***** ** ~$** ******* ** ~15% ** *****'* ***** *****.

********, *****'* ***** ** ***** *** grew **** **** **% **** **** year (**** $*.* ** $* *******), significantly ****** **** *****'* ******* ****** rate ** ~**%.

*******, ***** *** ******** $* ******* in *********** **** ***** ** *****, though **** ** * ******* ****** relative ** *****'* *********.

***** *** ********, ***. (“***** ***”) is ********** **** **** ***** *** entered **** * ************ ********* *** $2.0 ******* ** ********* ****** ** Convertible **** *****.

Brivo / ***** *** ******

*** *********** ** *********** ******* *** growing ********** ** ***** *** ***** for ***** *********** * **** *** a ********* ***** *********** / ****** with ***** *** ** *** ******. On *** ***** ****, ******** ******** for ******* **** ********** **** ***** Eye ** ******, ** ** **** be *********** ** *** *** *****, Brivo, *** ***** *** ******** *** obvious ********* ** ***** * **********.